• Sulfo-Cy3 NHS Ester (SKU A8107): Reliable Protein Labeling f

  2026-06-19

  This article addresses real-world laboratory challenges in fluorescent protein labeling for cell viability and proliferation assays, emphasizing the reproducibility and usability of Sulfo-Cy3 NHS ester (SKU A8107). Evidence-based Q&A scenarios highlight practical solutions, protocol optimization, and vendor reliability—empowering researchers to achieve robust, interpretable data with this hydrophilic fluorescent dye.

• Carbapenemase Gene Spread in CREC: Insights from Guangdong H

  2026-06-18

  This study systematically characterizes the prevalence and transmission dynamics of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong during the COVID-19 era. The findings highlight the dominance of blaNDM-1, high rates of mobile genetic element association, and significant multidrug resistance, offering actionable insights for resistance surveillance and experimental modeling.

• Ciprofloxacin: Mechanistic Leverage and Strategy in Translat

  2026-06-18

  This thought-leadership article provides a strategic roadmap for translational scientists leveraging Ciprofloxacin—a fluoroquinolone antibiotic—as both a mechanistic probe and a translational tool. By synthesizing the latest advances in antibacterial mechanism, resistance research, and innovative delivery strategies, the piece offers actionable guidance for designing robust, reproducible models and pioneering cross-domain applications. Drawing on recent evidence from nanotheranostic oncology and antimicrobial resistance workflows, the discussion moves beyond standard product pages to illuminate new frontiers in bacterial research and therapeutic development.

• HDAC8-Driven AKT Activation in MEK1/2 Inhibitor-Resistant Ca

  2026-06-17

  This study uncovers a novel resistance mechanism to MEK1/2 inhibitor therapies in cancer, demonstrating that HDAC8 upregulates PLCB1 and suppresses DESC1 to activate AKT in cells resistant to MAPK/ERK pathway inhibition. These findings highlight new molecular targets for overcoming resistance and optimizing targeted cancer therapies.

• PTH (1-34) in Translational Bone & Vascular Calcification Mo

  2026-06-17

  This thought-leadership piece bridges mechanistic insight and strategic workflow guidance for translational researchers leveraging Parathyroid hormone (1-34) (human) in bone metabolism and vascular calcification models. By integrating recent advances in CKD-related valvular calcification mechanisms with the unique experimental flexibility of the PTH (1-34) peptide fragment, the article delivers actionable recommendations for in vitro and in vivo study design. Emphasizing protocol structure, competitive landscape, and translational potential, it sets a new benchmark for experimental rigor and next-generation modeling.

• Saikosaponin D Overcomes Radioresistance in TNBC via MRE11 D

  2026-06-16

  The referenced study uncovers how Saikosaponin D sensitizes triple-negative breast cancer (TNBC) to radiotherapy by reversing lactate-induced MRE11 lactylation through the HIF1α/HDAC5 pathway. These findings clarify the metabolic-epigenetic mechanisms underlying radioresistance and highlight potential targets for improved TNBC treatment.

• FerroOrange Fe²⁺ Probe: Decoding Macrophage Ferroptosis in A

  2026-06-16

  Explore how the FerroOrange Fe²⁺ fluorescent probe empowers advanced intracellular iron detection in live macrophages, revealing critical insights into ferroptosis mechanisms in asthma. Discover unique assay guidance and scientific context not covered elsewhere.

• Ceramide-Driven Autophagy Facilitates Fish Nodavirus Replica

  2026-06-15

  This study employs global lipidomics to reveal that red-spotted grouper nervous necrosis virus (RGNNV) manipulates ceramide metabolism to enhance its own replication in fish cells. By linking ceramide accumulation to autophagy induction, the work uncovers new molecular targets for antiviral intervention and deepens our understanding of host–virus interactions in aquaculture.

• MDV3100 (Enzalutamide): Androgen Receptor Inhibition in CRPC

  2026-06-15

  MDV3100 (Enzalutamide) is a second-generation androgen receptor antagonist with proven efficacy in castration-resistant prostate cancer research. It induces apoptosis in AR-amplified cell lines and blocks androgen receptor nuclear translocation. This article summarizes molecular mechanisms, benchmark findings, and experimental best practices.

• Machine Learning Enables Discovery of Novel Senolytics

  2026-06-14

  The referenced study applies machine learning to identify previously unrecognized senolytic compounds, advancing efficient and cost-effective drug discovery in cellular senescence research. This approach reduces screening costs and accelerates the translation of computational predictions into validated anti-senescence therapies.

• Bsa I (RNase-free): Technical Guide for RNA-Sensitive DNA Cl

  2026-06-13

  Bsa I (RNase-free) addresses the need for precise, sequence-specific DNA cleavage in workflows where RNA integrity must be strictly preserved, such as gene cloning and DNA recombinant technology. This product is not intended for diagnostic or clinical use, and is best suited for research applications requiring RNase-free conditions.

• SC 79: Advanced Akt Activation Strategies for Neuroprotectio

  2026-06-12

  Explore how SC 79, a potent Akt activator, revolutionizes neuroprotection in ischemic stroke and cell survival studies. This article delves deep into mechanistic, translational, and methodological insights beyond standard protocols.

• Carfilzomib (PR-171): Precision Modulation of ER Stress for

  2026-06-12

  Explore how Carfilzomib (PR-171) enables advanced proteasome inhibition by targeting endoplasmic reticulum stress and multi-modal cell death in cancer research. This in-depth guide reveals unique mechanistic insights and essential protocol parameters for translational studies.

• Entinostat (MS-275): Precision HDAC1/3 Inhibition in Cancer

  2026-06-11

  Entinostat (MS-275) empowers oncology researchers to dissect HDAC-mediated gene regulation and achieve robust cancer cell proliferation inhibition. This article translates recent reference findings and real-world workflows into actionable protocols with troubleshooting tips for reproducible epigenetic modulation.

• VE-822 ATR Inhibitor: Enhancing Radiosensitization Workflows

  2026-06-11

  VE-822, a potent ATR inhibitor, empowers researchers to dissect DNA damage response inhibition while selectively sensitizing pancreatic and other cancer cells to chemoradiotherapy. This article delivers actionable workflow optimizations, troubleshooting guidance, and comparative insights—rooted in the latest 2D and 3D model evidence—to maximize experimental rigor and translational value.

450 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page